Hematologic diseases encompass a wide range of disorders affecting the blood and blood-forming organs, ranging from relatively benign conditions such as anemia, to more severe cancers of the blood. Common hematologic tumors include leukemia, lymphoma and multiple myeloma, which are characterized by the abnormal proliferation of blood cells or lymphatic tissue. These conditions necessitate specialized treatment approaches, such as chemotherapy, immunotherapy (including cellular immunotherapy), and hematopoietic cell transplantation. Timely diagnosis and tailored treatment are crucial for effectively managing these intricate hematologic diseases .Early diagnosis and personalized treatment plans are crucial for managing these complex hematologic diseases effectively.

GoBroad Healthcare Group (GHG) is a pioneer of the research-oriented hospital mode in China. We are trusted specialists in diagnosing and treating complex and serious hematologic diseases, dedicated to committed to providing high-quality, state-of-the-art healthcare at every stage of cancer treatment. Our medical services include:

• Focusing on the diagnosis and treatment of difficult and severe Hematologic Diseases such as leukemia, lymphoma, multiple myeloma, and thalassemia.
• Providing accurate diagnosis and individualized treatment. Individualizing the diagnosis and treatment plan for each patient by an effective combination of chemotherapy, radiotherapy, immunotherapy, targeted therapy, hematopoietic stem cell transplant and other technologies.
• Expanding the clinical application and research of CAR-T, innovative drugs and other advanced technologies to obtain more treatment options for refractory and relapsed patients.
• Safeguarding the whole treatment period for patients through efficient collaboration of the multidisciplinary team.